Skip to main content

Benjamin Elison Gewurz

NIH Rank #3444
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9613146Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2024

Linked Award Amount
$2.6M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#3,444
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Benjamin Elison Gewurz. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Benjamin Elison Gewurz as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA275301-03U01
    B cell determinants of EBV latency
    $827.3K
    award amount
  • 1R01DE033907-01R01
    Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling
    $528.2K
    award amount
  • 5R01AI164709-04R01
    Regulation of the Epstein-Barr Virus Lytic Switch
    $505.7K
    award amount
  • 5R21AI170751-02R21
    Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
    $268.5K
    award amount
  • 1R21AI181873-01A1R21
    Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis
    $223.8K
    award amount
  • 5P01CA269043-02P01
    Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
    $200.2K
    award amount
  • 1R13CA294854-01R13
    Epstein-Barr Virus/Kaposi Sarcoma Associated Herpesvirus 2024 Meeting
    $20.3K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Benjamin Elison Gewurz as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3444
  6. 2024
    Entered Top 25% Nationally
    Ranked #3444
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader